Search Results

You are looking at 41 - 50 of 473 items for :

  • Refine by Access: All x
Clear All
Full access

Jarred Burkart, Dwight Owen, Manisha H. Shah, Sherif R. Z. Abdel-Misih, Sameek Roychowdhury, Robert Wesolowski, Sigurdis Haraldsdottir, Julie W. Reeser, Eric Samorodnitsky, Amy Smith, and Bhavana Konda

revealed a large hemangioma but no other suspicious lesions ( Figure 1A ). MRI of the abdomen and pelvis confirmed imaging evidence of a 9.4 x 8.4-cm hemangioma, but also showed 2 small lesions in the inferior right lobe of the liver with ring enhancement

Full access

Brian J. Williams, Daniel M.S. Raper, Erin Godbout, T. David Bourne, Daniel M. Prevedello, Amin B. Kassam, and Deric M. Park

imaging, because plain radiographs often fail to diagnose chordoma and CT and MRI often end at S2. 15 , 18 , 19 Invasion and compression of adjacent neurologic structures can result in myriad symptoms, including weakness, numbness, bowel and bladder

Full access

Justin Famoso, Gerald Lemole, Srinath Sundararajan, and Baldassarre Stea

, which revealed a poorly defined hyperdense mass in the pineal region associated with moderate obstructive hydrocephalus. Follow-up MRI revealed a homogenously enhancing pineal lesion on T1-wighted images, inseparable from the tectum, that measured 3

Full access

Anastasia Drobysheva, Laura J. Klesse, Daniel C. Bowers, Veena Rajaram, Dinesh Rakheja, Charles F. Timmons, Jason Wang, Korgun Koral, Lynn Gargan, Erica Ramos, and Jason Y. Park

presented with persistent headache; MRI showed a solid and cystic posterior fossa tumor with patchy contrast enhancement. Over the next 7 years she underwent 3 incomplete surgical resections before experiencing progression with persistent growth of residual

Full access

Stuart L. Cramer, Rong Li, Siraj Ali, Julie A. Bradley, Hee K. Kim, and Joseph G. Pressey

progressive lower extremity weakness and bladder dysfunction. MRI revealed an epidural lesion extending from L3 to S2 level. The lesion showed low T1 and high T2 signal without contrast enhancement, suggesting a cystic lesion with neural foraminal extension

Full access

Pancreatic Adenocarcinoma, Version 2.2012

Featured Updates to the NCCN Guidelines

Margaret A. Tempero, J. Pablo Arnoletti, Stephen W. Behrman, Edgar Ben-Josef, Al B. Benson III, Ephraim S. Casper, Steven J. Cohen, Brian Czito, Joshua D. I. Ellenhorn, William G. Hawkins, Joseph Herman, John P. Hoffman, Andrew Ko, Srinadh Komanduri, Albert Koong, Wen Wee Ma, Mokenge P. Malafa, Nipun B. Merchant, Sean J. Mulvihill, Peter Muscarella II, Eric K. Nakakura, Jorge Obando, Martha B. Pitman, Aaron R. Sasson, Anitra Tally, Sarah P. Thayer, Samuel Whiting, Robert A. Wolff, Brian M. Wolpin, Deborah A. Freedman-Cass, and Dorothy A. Shead

70% to 85% of patients determined to have resectable tumors through CT were able to undergo resection. 8 , 10 – 14 During the institutional review of the NCCN Guidelines, a reviewer suggested that pancreas protocol MRI should also be listed as an

Full access

Gregory P. Kalemkerian and Shirish M. Gadgeel

, the most common sites are the lungs, pleura, bones, adrenal glands, liver, and brain. Standard procedures to identify metastatic disease include contrast-enhanced CT scans of the chest and abdomen, bone scan, and MRI or CT scan of the brain. Brain

Full access

Renee W. Pinsky and Mark A. Helvie

Group convened in 2007 in recognition of the limitations of the current risk model. 31 They have proposed a new comprehensive risk-predicting model that would include breast density, estrogen, and androgen assays and measurements such as BMI. MRI, with

Full access

Michelle T. Ashworth and Adil Daud

right leg and scrotal lymphedema, and high-dose interferon followed by a subcutaneous interferon for 1 year. The patient was monitored with serial PET/CT, MRI brain, and clinical examination. In 2007, a left calf melanoma in situ was treated with WLE. In

Full access

Christopher J. Long, Sameer Mittal, and Thomas F. Kolon

techniques and refinement in MRI modalities yield a more precise assessment of the tumor size, correlation with histologic subtype and response to chemotherapy, as well as anatomic considerations related to PN. 34 , 35 Tumor extension beyond the kidney